We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Primis Financial Corp
FRST
$409M
| $509K | ﹤0.01% |
31,151
+127
| +0.4% | +$2.01K |
|
2352
Heritage Insurance Holdings
HRTG
$915M
| $509K | ﹤0.01% |
38,413
+208
| +0.5% | +$2.86K |
|
2353
NWPX Infrastructure Inc
NWPX
$1.2B
| $509K | ﹤0.01% |
15,271
+205
| +1% | +$6.47K |
|
2354
Gates Industrial Corporation Ltd.
GTES
$7.42B
| $508K | ﹤0.01% |
36,918
-8,808
| -19% | -$100K |
|
|
MEET
2355
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $507K | ﹤0.01% |
101,229
+380
| +0.4% | +$1.79K |
|
2356
OrthoPediatrics
KIDS
$573M
| $506K | ﹤0.01% |
10,770
+111
| +1% | +$4.3K |
|
|
GDEN
2357
DELISTED
Golden Entertainment
GDEN
| $503K | ﹤0.01% |
26,147
+156
| +0.6% | +$2.55K |
|
|
CETV
2358
DELISTED
Central European Media Enterprises Ltd
CETV
| $502K | ﹤0.01% |
110,755
-540
| -0.5% | -$2.44K |
|
2359
Metropolitan Bank Holding Corp
MCB
$1.17B
| $501K | ﹤0.01% |
10,390
-45
| -0.4% | -$1.99K |
|
2360
RBB Bancorp
RBB
$456M
| $499K | ﹤0.01% |
23,594
+65
| +0.3% | +$1.32K |
|
2361
Rigel Pharmaceuticals
RIGL
$749M
| $499K | ﹤0.01% |
23,295
+390
| +2% | +$8.03K |
|
2362
Sportsman's Warehouse
SPWH
$46M
| $498K | ﹤0.01% |
62,058
-592
| -0.9% | -$4.18K |
|
2363
A10 Networks
ATEN
$2.22B
| $497K | ﹤0.01% |
72,291
-379
| -0.5% | -$2.55K |
|
2364
KRONOS Worldwide
KRO
$714M
| $497K | ﹤0.01% |
37,061
+324
| +0.9% | +$4.25K |
|
2365
Arcus Biosciences
RCUS
$3.48B
| $497K | ﹤0.01% |
49,213
+354
| +0.7% | +$2.98K |
|
|
TLRA
2366
DELISTED
Telaria, Inc.
TLRA
| $497K | ﹤0.01% |
56,427
+357
| +0.6% | +$2.79K |
|
2367
First Bancorp
FNLC
$399M
| $495K | ﹤0.01% |
16,369
-52
| -0.3% | -$1.48K |
|
2368
Park-Ohio Holdings
PKOH
$599M
| $495K | ﹤0.01% |
14,699
+77
| +0.5% | +$2.43K |
|
2369
UFP Technologies
UFPT
$2.49B
| $495K | ﹤0.01% |
9,970
-45
| -0.4% | -$1.96K |
|
2370
Goldgroup Mining Inc.
GORO
$163M
| $489K | ﹤0.01% |
88,256
+506
| +0.6% | +$2.21K |
|
2371
Bridgewater Bancshares
BWB
$588M
| $487K | ﹤0.01% |
35,335
+537
| +2% | +$6.81K |
|
|
AXNX
2372
DELISTED
Axonics, Inc. Common Stock
AXNX
| $487K | ﹤0.01% |
17,558
+339
| +2% | +$8.09K |
|
|
CATC
2373
DELISTED
CAMBRIDGE BANCORP
CATC
| $487K | ﹤0.01% |
6,074
-109
| -2% | -$8.49K |
|
2374
Home Bancorp
HBCP
$567M
| $486K | ﹤0.01% |
12,391
-95
| -0.8% | -$3.69K |
|
2375
Blue Bird Corp
BLBD
$2.43B
| $484K | ﹤0.01% |
21,108
+50
| +0.2% | +$999 |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.